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GLASS DERIVED NANOPARTICLES FOR NERVE TISSUE REPAIR
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of U.S. Provisional Patent
Application No. 62/048,146 filed September 9, 2014 and U.S. Provisional Patent
Application No. 62/048,148 filed September 9, 2014, the entire disclosures of
which are both incorporated herein by reference.
FIELD OF THE INVENTION
[0002] The present invention relates to doped biodegradable glass compositions
and methods of treating nerve damage using doped biodegradable glass to
deliver nanoparticles.
BACKGROU ND
[0003] Ideal nerve repair biomaterials or scaffolds should be biocompatible
and noninflammatory, yet flexible with adequate tensile strength to prevent nerve
compression. The materials should be biodegradable with a porosity and
permeability to supply adequate oxygen and nutrients. Nerve autografts remain
the gold standard in nerve repair and regeneration because of their performance.
However, autografts require additional surgery, donor site morbidity, and the loss
of nerve function; all reasons that alternative materials in nerve repair and
regeneration are needed.
[0004] Bioresorbable synthetic natural polymers such as type I collagen
(for example the NeuraGen™ collagen tube available from Integra LifeSciences
of Plainsboro, NJ) have received attention over the last decade due to ease of
production and controlled degradation. Type I collagen supports cell attachment,
unidirectional proliferation, and growth in vivo. The disadvantages to synthetic
natural polymers include irreproducibility of collagen type I and the need for
immunosuppressant drugs to reduce host rejection. Resorbable synthetic
polymers have been used extensively to repair peripheral nerves due to lower
cost, simple fabrication, and proven efficacy. Compared to an autograft, these
synthetic materials eliminate the shortcomings of the autograft.
[0005] Over the past 50 years many methods have been developed to
produce different types of inorganic materials with different sizes, shapes and
properties. Most of these methods use a soluble salt such as nitrate or carbonate
to provide the desired ions in a solution and then use other chemicals or
processes to precipitate or reduce from an ionized to neutral form. However,
small materials such as nanomaterials can be formed through other routes like
Sol-Gel processing, Microemulsion, Hydrothermal/Solvothermal processing,
Templated synthesis, and Biomimetic Synthesis.
[0006] Therefore, a need exists for methods for creating and delivering
nanoparticles of different chemical composition, size, and shape formed within a
biodegradable, biocompatible inorganic glass, to improve nerve regeneration and
improve the quality of life following injury to the spinal cord or peripheral nerves.
SUMMARY
[0007] Provided herein is a biocompatible, biodegradable composite
material for soft tissue repair, such as repair of nerve or nerve cells, and related
methods of use. A biocompatible, biodegradable composite material as
described herein includes a matrix material and a parent glass suspended within
the matrix material, the parent glass including a glass and a dopant. The parent
glass may release a plurality of dopant-based nanoparticles upon contact and
reaction with a body fluid or a simulated body fluid. The glass may comprise, for
example, a borate glass such as sodium tetraborate, or a borosilicate glass. The
dopant may be selected from a metal ion, a transition metal ion, an oxide, a rare
earth oxide, a halide, carbonate, a compound containing a cation, and any
combination thereof. The dopant may be selected from CeO2, Ce2O3, Y2O3, and
ZrO2 and mixtures of any two or more thereof. The dopant may be selected from
Co, Ni, Cu, Ag, Au, Pt, Fe, Ru, Si, V, Cr, Mn, Fe, Ni, Zn, Sn, Sb, Zn, Ti, Y , Zr, W ,
La, Ce, Pr, Nd, Sm, Eu, Lu, Yb, Er, Ba, Ga, I, N, S, Si, and any combination
thereof. The dopant may be selected from the combinations l/Ce, l/Y, l/Ce/P,
and Cu/Zn/Sr/Fe. The parent glass may include Na2O.2B 2 O 3.xCeO2 and x
ranges from about 0.001 to about 0.30 moles. The biocompatible, biodegradable
composite material may be degradable in vivo. The biocompatible,
biodegradable composite material may further include a therapeutic agent. The
matrix material of the biocompatible, biodegradable composite material may
comprise a material selected from a polymer, a ceramic, and any combination
thereof. The matrix material may for example be selected from collagen, laminin,
fibrin, PCL, PLA, PLLA, PEG, PGA, PLGA and any combination thereof. The
parent glass may have a conformation selected from irregular particles,
microspheres, fibers, rods, ribbons and any combination thereof. Any of the
foregoing conformations of a biocompatible, biodegradable composite material
may be combined with a second matrix material, which may comprise any
scaffold material such as collagen, laminin, fibrin and any combination thereof. A
combination of any conformation of a biocompatible, biodegradable composite
material and a second matrix material can be formed in any shape, such as for
example a generally cylindrical conduit form.
[0008] Further provided herein are methods of delivering nanoparticles to
a region of interest, including placing any biocompatible, biodegradable
composite material as described herein, in or in contact with a body fluid or
simulated body fluid; and allowing the parent glass to react and/or degrade to
form and release the nanoparticles. It should be understood that the body fluid
or simulated body fluid may be combined or associated with a region of interest
in the body, such as a body tissue. The region of interest may be for example
any suitable location relative to nerve cells, which may be in a tissue or in a body,
such as but not limited to a peripheral nerve, or the spine and/or spinal cord.
BRIEF DESCRIPTION OF THE DRAWINGS
[0009] The following figures illustrate various aspects of the disclosure.
[001 0] FIG. 1 is an x-ray diffraction pattern, showing the electron
diffraction pattern for the as-made borate glass with the molar composition
[001 1] FIGS. 2A-B are TEM images of nanoparticles formed from the
borate glass with the composition Na2O.2B 2O3.0.01 CeO2 reacted in Dl-water at
room temperature. FIG. 2A is a low magnification TEM image of nanoparticle
clusters. FIG. 2B is a high magnification TEM image of nanoparticles
(boundaries of two individual nanoparticles selected randomly identified with
outline).
[001 2] FIGS. 3A-B are TEM images of nanoparticles formed from the
borate glass with the molar composition Na2O.2B2O3.0.01 CeO2 reacted in SBF at
37°C. FIG. 3A is a low magnification TEM image of nanoparticle clusters. FIG.
3B is a high magnification TEM image of the nanoparticles.
[001 3] FIGS. 4A-B are images of nanoparticles (agglomerated) formed
with the borate glass with the composition of Na2O.2B 2O3.0.01 CeO2 doped with 1
wt.% Y2O3 (FIG. 4A) and 1 wt.% ZrO 2 (FIG. 4B), which was reacted in Dl water
at 37°C. The scale mark is 20 nm.
[0014] FIGS. 5A-C are images of live cells for control (FIG. 5A), Ce1 (FIG.
5B), and Y 1 (FIG. 5C).
[001 5] FIG. 6 is a graph depicting the mean +/- standard error for the
mean percent (%) number of live neurons for the 4 different sets of wells imaged
per condition at day 7 and day 10. Statistical analysis was performed with a two
sample t-test with data considered significantly different than control for the same
days in culture (* p<0.05; * * p<0.01 ) .
[001 6] FIGS. 7A-C are photographic images of the forms of fabricated
glass. FIG. 7A shows small glass frit doped with cobalt (blue); polymer sheets
with punches made, "cotton balls" of glass microfibers, and the glass rods. FIG.
7B shows polymer/glass composite sheets can be rolled and punched. FIG. 7C
shows long glass rods can be formed or broken into smaller lengths, shown as
added to cells in culture.
[001 7] FIG. 8 is scanning electron micrographs of biodegradable 1393-B3
glass (left images) compared to the same magnification of Y-containing B3 glass
(right images).
[001 8] FIGS. 9A-B show scanning electron micrographs of biodegradable
glass microfibers that show the ultrafine cotton ball fiber-like structure at two
magnifications.
[001 9] FIGS. 10A-D are images of rods (A, C) and microfibers (B, D)
taken at 1 week and 9 weeks in media showing the reaction and degradation of
biodegradable 1393-B3 glass rods and microfibers with cell culture over time.
Scale bar = 100 µιτι .
[0020] FIGS. 11A-C are optical images of the air-side (A) and the glass
side (B) of the glass ( 1393-B3)/polymer composite sheet. After immersion for 14
days in SBF, images show the changes in the air-side of a 100% PCL sheet (C)
compared to the air-side of the 1393-B3 glass (D). Inset shows higher
magnification of the islands of agglomerated Hydroxyapatite (HA).
[0021] FIG. 12A-B are scanning electron micrographs of HA microspheres
on the surface and within the cross-section (A) after immersion of glass/polymer
composite (Blend Composite: 25wt% 1393-B3, 25wt% 45S5, 50wt% PCL) in SBF
for 14 days. An expanded image of the section shown in the box (B) shows the
HA microspheres.
[0022] FIGS. 13A-D are graphs showing the weight loss (A) and ion
release of Boron ions (B), Calcium ions (C), and Phosphorus ions (D) over time
for a composite composed of 50 wt. % PCL/50 wt. % B3 (squares) compared to
100% PCL (triangles). Splines are only for guidance.
[0023] FIG. 14 is a schematic of the sciatic peripheral nerve model with a
biodegradable glass/polymer rolled or cylindrical conduit, with glass rods or
microfibers comprising a biocompatible, biodegradable composite material as
disclosed herein, embedded within second matrix comprising a collagen (CN)
gel, either with or without crosslinking to growth factors and/or drugs.
[0024] FIG. 15 is a schematic of repair of a spinal cord hemi-section. The
doped BG rods or microfibers can be embedded into collagen and injected at the
site of injury.
[0025] FIGS. 16A-C are graphs of mechanical properties for peak stress
(A), strain at break (B), and elastic modulus (C) for the composites that are either
unreacted or reacted for 3 or 6 weeks in media. For each graph, asterisks
denote statistical significance at p<0.05 for either the B3, Blend, or 45S5 for each
condition in (A) and (B), or B3 compared to PCL (C). Significance is indicated in
(C) for 45S5 greater than B3(#).
[0026] FIG. 17 is a photograph of sciatic nerves sutured to rolled PCL/B3
glass composite which has an average suture retention strength of 0.35 ± 0.07 N.
[0027] FIG. 18 shows images of live, dead, and the merge of live plus
dead cells of a dish of dissociated neurons not exposed to any glass. Scale bar
is 100 µιτι .
[0028] FIG. 19A is a graph of the average number of neurons and FIG.
19B is a graph of the average number of support cells comprised of fibroblasts
and glia for 3, 7 , and 10 days for each of the 13-93 B3 biodegradable glass
doped with the element shown along the x axis. For each of the conditions, the
cells were treated with about 14 mg/mL of the degradable glass. The Ce2 and Y2
glasses both contain trace amounts of iodine, and the CZSF glass contains a
mixture of Cu, Zn, Sr, and Fe ions.
[0029] FIG. 20A is a graph of the average neurons normalized to the total
number of cells (Live plus Dead) and FIG. 20B is a graph of the average neurons
normalized to the total live cells (neurons plus support cells). The graphs show
normalized average number of neurons for each of the types of B3
biodegradable glass doped with the element shown along the x axis. For each of
the conditions, the cells were treated with about 14 mg/mL of the degradable
glass. The Ce2 and Y2 both contain trace amounts of iodine, and the CZSF glass
consists of Cu, Zn, Sr, and Fe ions.
[0030] FIGS. 2 1A-D are graphs of a few selected biodegradable borate
based glass to compare the effects of adding more glass to increase the
concentration of released ions as the glass reacts in the cell media. Results are
shown for only the percent of live neurons/total live cells for 1, 2, 4, and 8 pieces
of 1 cm long glass rods, that is approximately 7, 14, 28, and 56 mg/mL of
biodegradable glass per ml_ of media, respectively.
[0031] FIG. 22 shows whole DRG extended neurites on bioactive borate
glass composite sheets. Images of whole DRG stained with Calcein AM show
the composites support outgrowth of neurites from the body of the DRG. Scale
bars = 100 µιτι . The average neurite outgrowth from the DRG body is shown for
each of the dopants tested, and compared to the control 13-93 B3 glass. Fe
supports greater outgrowth than Ce1 , Y 1, and Y2 (* p<0.05); Zn supports greater
outgrowth than Y 1 (#p<0.05).
[0032] FIG. 23 is a graph of whole DRGs whose neurites had measured
extension lengths on the composites of undoped biodegradable glasses when
either pre-reacted for 6 weeks or unreacted. Unreacted 45S5 composite
exhibited greater outgrowth than any other unreacted PCL or polymer sheet
(* p<0.05). After pre-reaction, B3 exhibited greater outgrowth than the blend
composite (#p<0.05), but not any differences with the 100% PCL or the 45S5
composite.
[0033] FIG. 24 is a bar graph of the single longest neurite outgrowth
measurement per DRG after three (3) days in culture, for each dopant tested.
[0034] FIG. 25 shows measurement of directed neurite outgrowth on
aligned 13-93 B3 glass rod/fibrin scaffolds. FIG. 25A shows a representative
fluorescent image of DRG stained with Calcein AM. Scale bar is 200 µιτι . FIG.
25B is a graph of neurite and neurite bundle outgrowth from DRG aligned with
rods, in which 0 and 180 degrees is considered aligned. FIG. 25C is a schematic
that show the orientation of the glass rods with the angle of extension measured
by outgrowth from the DRG body.
[0035] Corresponding reference characters and labels indicate
corresponding elements among the views of the drawings. The headings used in
the figures should not be interpreted to limit the scope of the claims.
DETAILED DESCRIPTION
[0036] Provided herein are materials and methods of nerve repair in which
a biocompatible, biodegradable composite material is used to produce and
deliver a nanomaterial. In various aspects, the biocompatible, biodegradable
composite material comprises a glass, which is biocompatible and
biodegradable, suspended in a matrix. The glass contains inorganic dopants
which are released as ions when the composite comes into contact with a body
fluid or simulated body fluid. A biocompatible, biodegradable composite material
as disclosed herein may be used to produce and deliver nanomaterials to cells or
tissues in vivo or in vitro.
[0037] As used herein, the term "subject" refers to an animal, including but
not limited to a mammal including a human and a non-human primate (for
example, a monkey or great ape), a cow, a pig, a cat, a dog, a rat, a mouse, a
horse, a goat, a rabbit, a sheep, a hamster, a guinea pig).
[0038] Unless otherwise defined herein, scientific and technical terms
used in connection with the present disclosure shall have the meanings that are
commonly understood by those of ordinary skill in the art. The meaning and
scope of the terms should be clear, however, in the event of any latent ambiguity,
definitions provided herein take precedent over any dictionary or extrinsic
definition. Further, unless otherwise required by context, singular terms as used
herein and in the claims shall include pluralities and plural terms shall include the
singular.
[0039] The use of "or" means "and/or" unless stated otherwise.
Furthermore, the use of the term "including", as well as other forms, such as
"includes" and "included", is not limiting. Also, terms such as "element" or
"component" encompass both elements and components comprising one unit
and elements and components that comprise more than one subunit unless
specifically stated otherwise.
[0040] The term "body fluid" as used herein refers to a liquid that
originates from inside the organism of a subject, including for example blood,
interstitial fluid, cerebrospinal fluid, or lymph. The term "simulated body fluid" as
used herein refers to a liquid having an ionic composition comparable to that of a
body fluid. In non-limiting example, a simulated body fluid can be a buffered
saline solution.
[0041] Generally, nomenclatures used in connection with, and techniques
of, cell and tissue culture, molecular biology, immunology, microbiology, and
chemistry described herein are well known and commonly used in the art. The
methods and techniques of the present disclosure are generally performed
according to conventional methods well known in the art and as described in
various general and more specific references that are cited and discussed
throughout the present specification unless otherwise indicated. Any chemical,
enzymatic or staining reactions, or purification techniques are performed
according to manufacturer's specifications and protocols, as commonly
accomplished in the art or as described herein. The nomenclatures used in
connection with, and the laboratory procedures and techniques of, analytical
chemistry, synthetic organic chemistry, and medicinal and pharmaceutical
chemistry described herein are also well known and commonly used in the art.
Standard techniques are used for chemical syntheses, chemical analyses,
pharmaceutical preparation, formulation, delivery, diagnosis and treatment of all
subjects, human and animal.
[0042] In one aspect, a biocompatible, biodegradable composite material
comprises a glass comprising a nanomaterial. The nanomaterial is for example a
nanoparticle. The size, shape, and chemical composition of a given type of
nanoparticle can be controlled by the synthesis process. For example, chemical
dopants can be added to the parent glass composition to contain the desired
percent composition of compounds. By way of non-limiting example, dopants
can include an oxide, halide, carbonate or any other type of compound that may
contain or produce a desired cation. The parent glass for making the
nanoparticles may be formed by melting the doped glass under controlled
conditions (melting atmosphere, temperature and time) and cooling the glass in a
controlled manner. The parent glass may then be degraded, in vivo or in vitro,
forming the nanoparticles in the process.
[0043] Two primary types of biomaterials are available for use in
connection with the present disclosure: biodegradable materials that degrade
with time, or bio-inert materials that do not degrade. The bio-inert materials may
be unreactive to provide long-term structural support. These may be used
predominantly as scaffolding in bone and hard tissues for regeneration. In
contrast, biodegradable materials react and degrade with time in the body, or
when subjected to simulated body fluids (SBF) or cell culture media. These
biodegradable materials may be better suited to soft tissue regeneration as with
time, as the tissues regrow and infiltrate the damaged regions, the biodegradable
material will react with simulated body fluids and be absorbed by the body as the
scaffold is no longer required, thus leaving only the regenerated tissue in its
place. Provided herein are biodegradable materials optimized for reacting and
degrading with appropriate time for soft tissue repair, and while doing so, provide
the needed structural scaffold and delivery system for advantageous chemical
dopants and molecules. It may also have the ability to chemically cross-link and
deliver drugs and growth factors. Optimization of this system may provide a
better-suited soft tissue regenerative system than what currently exists for soft
tissue regeneration and repair.
[0044] In an aspect, borate based biodegradable glass with added
chemical dopants may be fabricated in many different forms such as
nanoparticles, irregular shaped particles (frit), rods, spheres, and microfibers.
This biodegradable glass may be used for soft tissue repair and nerve
regeneration. The addition of chemical dopants such as Ce or Y has been shown
to be neuroprotective to neurons in vitro, as well as prevent overproliferation of
the scar forming fibroblasts. In various aspects, the forms of glass may be used
as composites or mixed materials in scaffolds and nerve guide conduits to
promote regeneration of peripheral and central nerves that have been damaged
through trauma or disease, as well as promote the regrowth of nearly any type of
soft tissue.
I. Nanomaterials
[0045] A biocompatible, biodegradable glass composite material as
disclosed herein may include a parent glass that contains or releases desired
cations, and/or creates nanoparticles. The parent glass may be semi-crystalline
or non-crystalline/amorphous, and the nanoparticles may be crystalline or non-
crystalline/amorphous. In one aspect, the parent glass reacts or degrades when
exposed to fluid(s), for example a body fluid or a simulated body fluid (SBF) in
vivo or in vitro, and may generate non-crystalline/amorphous nanoparticles. The
parent glass may be, for example, biocompatible and non-toxic.
[0046] The materials synthesized may be formulated by methods to deliver
inorganic nanomaterials in situ using biocompatible, biodegradable glasses. In
one aspect, the nanomaterials are nanoparticles. The nanomaterials may be
produced in two different ways. Methods of making nanoparticles include a solid-
state (glassy-state) method to produce nanoparticles using a degradable glass
as disclosed herein. In this method, nanoparticles may be produced in two
different ways. In a first method, the desired nanoparticle base material (metal
ions, transition metal ions, rare earth oxide, etc.) may be dissolved in a glass
melt to form the parent glass. In one aspect, the parent glass may be doped with
an oxide, halide, or other compound containing a desired cation. Then the
parent glass may be reacted or degraded in a desired fluid in a laboratory (e.g.,
in vitro) or inside the body of subject (in vivo). As the glass reacts or degrades
the desired ions may be released to form nanoparticles of a desired
composition/size. A second method may be to dissolve the desired material in
the molten glass and then form the nanomaterials inside the glass using
techniques such as controlled heat treatments, radiation, etc., as will be
understood by those of skill in the art. The glass may then be reacted or
degraded in vitro or in vivo to release the nanoparticles. In this second method,
the glass network may react when in contact with a body fluid or simulated body
fluid, while the insoluble nanoparticles remain in the fluid, at least temporarily.
The nanoparticles may for example remain in solution in vivo until they are
removed or sequestered by the body.
[0047] The glass and other desired compounds may be mixed as
powdered raw materials. In one aspect, the glass raw material may be a borate
glass such as sodium tetraborate, or a borosilicate glass. In another aspect, the
nanoparticle base material may be a dopant. The size, shape, and chemical
composition of a given type of nanoparticle can be controlled by doping the
parent glass with the desired amount of a chosen oxide, halide {e.g., F, CI, I),
carbonate, or other type of compound (e.g., sulfate, oxalate, or nitrate) that
contains the desired cation, (e.g., Ce, Y, Zr, Gd) and melting the doped glass
under (a) controlled conditions (melting atmosphere, temperature and time), and
(b) cooling the glass in a controlled manner. In an aspect, powdered sodium
tetraborate and CeO2 may be mixed together to form a parent glass mixture of
sodium borate glass.
[0048] In one aspect, the parent glass may have the molar composition of
Na2O.2B2O3.xCeO2, where x ranges from about 0.001 to about 0.30 moles. In
another aspect, the parent glass may have the molar composition
xNa2O.2xB 2O3.(1 -3x)AI2O3, where x ranges from about 0 to about 0.2 moles. In
an aspect, the parent glass may have the molar composition xR O.yR'O.(1 -x-
y)B O3, where R may be alkali ions such as Li, Na, K, etc. and R' may be alkaline
earth ions such as Mg, Ca, Sr, etc. and where x ranges from about 0 to about 0.5
moles and y ranges from about 0 to about 0.5 moles. In yet another aspect, the
parent glass may be xR2O.yR'O. zR2"O3. m R2'"O5 .(1 -x-y-z)B2O3, where R may
be alkali ions such as Li, Na, K, etc., R' may be alkaline earth ions such as Mg,
Ca, Sr, etc., R" may be modifiers that form a R' 203 oxide such as Al, Fe, etc.,
and R'" may be modifiers that form a R'"2O5 oxide such as phosphorus (P) and x
and y range from about 0 to about 0.5 moles, and z and m range from about 0 to
about 0.2 moles.
[0049] Non-limiting examples of nanoparticle base material dopants for
producing metallic ionic nanomaterials include Co, Ni, Cu, Ag, Au, Pt, Fe, and
Ru. Non-limiting examples of nanoparticle base material dopants for producing
oxides, phosphate, and borate nanoparticles may include Si, V, Cr, Mn, Fe, Ni,
Zn, Sn, Sb, Zn, Ti, Y, Zr, W, La, Ce, Pr, Nd, Sm, Eu, Lu, Yb, and Er. Dopants
that may be used for soft tissue regeneration include, but are not limited to Ag,
Ba, Ce, Co, Cu, Fe, Ga, I , Mn, N, S, Si, Sr, Ti, Y, and Zn, and a mixture of
elements such as: l/Ce (Ce2), l/Y(Y2), l/Ce/P, and Cu/Zn/Sr/Fe (CZSF). Two or
more of these dopant elements may be combined within the nanoparticles. In an
aspect, Y or La doped CeO2 nanoparticles may be produced (co-doped cerium
oxide-yttrium nanoparticles). In another aspect, the parent glass may contain up
to about 4 dopants.
[0050] The parent glass mixture may be heated from about 600°C to about
1000°C, forming a parent glass melt. In an aspect, the parent glass mixture may
be heated to about 1000°C for about 1 hour. The parent glass melt may be
cooled to from about 20°C to about 25°C in various aspects. In an aspect, the
parent glass melt may be cooled to room temperature to form the parent glass.
In this aspect, the nanoparticles may form during the dissolution of the glass in
aqueous solution.
[0051] In one aspect, a solid amorphous (glass) or semi-crystalline
(glassceramic) material may be used to make nanoparticles. For example,
nanoparticles can be formed by giving the glass a prescribed heat treatment
such that the desired nanoparticles are formed within the melted glass matrix,
which is then cooled and solidified. The resulting solid glass matrix containing a
controlled and specified amount of nanoparticles can then be delivered to a
desired site in humans or animals in several ways.
[0052] The heat treatment of the glass may include cooling the glass melt
to a certain temperature and holding it for a chosen time before cooling to room
temperature. In another aspect, the heat treatment may include cooling the glass
melt to room temperature and then reheating to a certain temperature and
holding for a chosen time before re-cooling to room temperature. In yet another
aspect, the glass melt may be bubbled with gas to form the nanoparticles within
the parent glass. The bubbling gas may be reducing (forming gas, CO/CO2
mixture), neutral (N2, Ar, He), or oxidizing (pure oxygen). The gas flow rate may
be from about 0.1 cm3/min to about 1000 cm3/min depending upon the
size/volume of the melt. The bubbling time may range from about 5 minutes to
about 72 hours depending up on the melt temperature and composition, dopants
in the melt, and melt size/volume. The bubbling temperature may be any
temperature where the viscosity of the melt is low enough to permit the gas to
escape from the melt. In one aspect, the viscosity may be lower than 10 poise.
[0053] The nanoparticles may be made and/or released by reacting the
glass in contact with a desired fluid under certain reaction conditions {e.g., of
temperature, pressure, pH, etc.). Physiological conditions can be used.
Alternatively the temperature for reacting the glass in vitro may range from about
-20 to about 120 °C under ambient pressure or up to about 500 °C under higher
pressures. The pH of the fluid for reacting the glass in vitro may range from
about 2 to about 12 . In one aspect, the glass composite materials can be
designed to react or degrade over the span of minutes to years. Additionally, it
will be understood that by changing various conditions such as temperature or
solution compositions, it may be possible to form a variety of nanomaterials with
special/different properties.
[0054] In another aspect, the body fluid or simulated body fluid may
contain added organic or inorganic stabilizers or surfactants to stabilize the
nanopartides and prevent them from agglomerating. Non-limiting examples of
such stabilizers include tetrahydrofuran (THF), ethylene glycol (EG),
hexadecylamine (HDA), mercaptosuccinic acid (MSA), poly(vinylpyrrolidone)
(PVP), CTAB, and Polyvinyl Alcohol (PVA).
[0055] In any of the foregoing aspects, the nanopartides may be less than
10 nm. In any aspect, the nanopartides created from the parent glass may
range in size from about 2 nm to about 60 nm. In any aspect, the nanopartides
may range in diameter from about 2 nm to about 20 nm, from about 10 nm to
about 30 nm, from about 20 nm to about 40 nm, from about 30 nm to about 50
nm, and from about 40 nm to about 60 nm. In any aspect, it will be understood
that the size of the nanopartides may be affected by the composition of the
parent glass, temperature, and pH.
II. Biomaterials from the Nanopartides and Biodegradable Glass
[0056] A biodegradable glass composite material as disclosed herein
includes for example a parent glass containing or capable of forming
nanopartides, and a matrix material. Nanopartides can be formed in various
ways. Glass raw materials may be mixed with nanoparticle base materials to
form a parent glass mixture. The parent glass mixture is heated to a first
temperature, forming a parent glass melt. The parent glass melt is cooled to a
second temperature to solidify the parent glass melt. In so doing, the parent
glass may be formed into a desired shape using standard shaping techniques as
known in the art, which may then in use be degraded or otherwise react upon
contact with a body fluid or simulated body fluid, wherein the nanopartides are
created as the parent glass reacts or degrades. For example, a borate glass
composite containing cerium may in use produce ceria nanopartides. Methods
of making nanopartides include the solid-state (glassy-state) method and other
methods as described in detail above in section I . Methods of using a
biodegradable glass composite material as disclosed herein are described in
further detail below in section III.
[0057] The parent glass or matrix material may further include one or more
therapeutic agent. This may include chemotherapeutics, growth factors,
angiogenic compounds, or any other substance that may be beneficial to the
region of interest. The therapeutic agent may diffuse out of the parent glass
faster than the nanoparticles are formed. In an aspect, the therapeutic agent
may provide a synergistic effect with the nanoparticles. The therapeutic agent
may, for example, be copper, iron, zinc or strontium.
[0058] The nanoparticles and parent glass may be incorporated into many
forms such as, for example, small irregularly shaped glass particles (frit),
microfibers, microspheres, thin flexible polymer sheets, and micron diameter
rods. FIG. 7 shows photographs of various forms of biodegradable glass that
may be fabricated and used towards soft tissue repair. The biodegradable glass
may be fabricated in many different forms, such as, but not limited to irregular
particles, microspheres, fibers, rods, to ribbons in different sizes, and may be
mixed with, or coated, on a polymer, metal, ceramic, or composite of desired
composition to provide a delivery system. The size of the biodegradable glass
material may be on the micron scale. In an aspect, the biodegradable glass rod
may be about 0.2 µιτι to about 400 µιτι in diameter.
[0059] Delivery of nanoparticles created from the biodegradable glass may
include injection of the nanoparticles alone, or as a suspension within a matrix
material of soluble gels that will degrade with time (hours to weeks), insertion by
surgical intervention, or placement at desired locations such that the linked or
unlinked nanoparticles can be released over time into the body fluids at the site
as the glass degrades in the body fluids. In an aspect, the nanoparticles may be
suspended in a matrix material. In another aspect, the parent glass may be
suspended in the matrix material. In yet another aspect, the parent glass may be
on the surface of the matrix material.
[0060] In one aspect, the matrix material may be, but is not limited to
collagen, laminin, fibrin, polycaprolactone (PCL), polylactic acid (PLA),
poly(lactic-co-glycolic acid) (PLGA), poly-L-lactide (PLLA), polyethylene glycol
(PEG), any other biodegradable polymer matrix material, and combinations
thereof. The matrix material and parent glass may be present in a mixture ratio
of matrix material to parent glass from about 20:80 to about 40:60, from about
30:70 to about 50:50, from about 40:60 to about 60:40, from about 50:50 to about
70:30, and from about 80:20 to about 60:40. The parent glass may be present
within the matrix material as a gradient from high dopant concentration to low
dopant concentration. In another aspect, the parent glass may be evenly
distributed throughout the matrix material. Multiple dopants with varying release
rates and/or solubility may be included within a matrix material to provide a
delayed release or gradient.
[0061] In another aspect, a biocompatible, biodegradable composite
material may formed initially as a flat sheet which is then rolled in the form of a
generally cylindrical conduit. Such a conduit may be any size, and in one
example can be usefully formed to be about 10mm to about 20mm long, about 3
mm to about 5 mm in outer diameter, and have a thickness of about 3 to about 4
rolls of the polymer sheet, wherein the thickness ranges from about 25 µιτι to 250
µιτι . The conduit may be porous in one aspect. In another aspect, as described
in further detail below, a biocompatible, biodegradable composite material in
various conformations may be combined with a second matrix material. For
example, a matrix material sheet containing a biodegradable composite material
may be rolled into a conduit shape which may be filled with another matrix
material containing a biodegradable composite material with the same or a
different dopant. In one of many possible examples, a biodegradable composite
material comprising PCL as the matrix and formed as a sheet may then be
formed into a conduit which contains, or surrounds a gel-like scaffold material
such as collagen or fibrin, in which a second biodegradable composite material is
suspended or contained.
[0062] Because of their biodegradability, poly ε -caprolactone (PCL) and its
copolymers have been used for soft tissue regeneration applications including
peripheral nerves. PCL slowly degrades in vivo and its degradation can take
several years depending upon its molecular weight. Furthermore, the
degradation rate of PCL can be altered by polymerization with other polymers
such as poly-lactic acid (PLA). Other copolymers may be used in place of PCL.
Addition of inorganic materials like biodegradable glass to a biodegradable
polymer improves the mechanical strength and enhances wetting properties of
certain polymers, which can improve cell adhesion. Together these properties of
copolymers provide the structural scaffold to develop a mixed biomaterial
consisting of biodegradable glasses to help heal and repair wounds, regenerate
nerves and repair other soft tissues such as blood vessels, and soft tissues such
as muscle, liver, and kidney.
[0063] In one aspect, biodegradable glass composites may be fabricated
in PCL or another such polymer as shown in FIG. 7 (polymer sheets). The
polymer sheet may then be rolled to form a cylindrical conduit. About 1.14g of
PCL (molecular weight about 70,000) may be dissolved in about 15 ml of
chloroform. The desired amount of glass particles may then be added to the
PCL/chloroform solution, stirred for about 30 min, and ultrasonicated several
times at about 1 min intervals. The glass/PCL mixture may be poured onto a
polished glass plate and a film of the mixture may be tape-casted using a blade
set at a thickness of about 600µηη . In an aspect, the glass plate may be about 8
cm wide and about 50 cm in length. The composite film may be dried at room
temperature for about 30 min, removed from the glass plate, and stored in a
desiccator.
[0064] The thickness of the dried films, measured with a micrometer at
several locations, may be about 60 ± 10 µιτι . In various aspects, the thickness of
the dried films may range from about 45 µιτι to about 55 µιτι , from about 50 µιτι to
about 60 µιτι , from about 55 µιτι to about 65 µιτι , from about 60 µιτι to about 70
µιτι , and about 65 µιτι to about 75 µιτι . In one aspect, the composition of the 13-
93 B3 borate glass (in wt.%) may be: 53% B2O3, 20% CaO, 12% K2O, 6% Na2O,
5% MgO, and 4% P2O.
[0065] Bioglass composites may be fabricated consisting of varying
percentages of PCL and 13-93 B3 glass chemically doped with varying types and
quantities of dopants. Additionally, in place of PCL, other types of polymers that
are inert and degrade with time may be substituted with many other polymer
materials used commonly in conduits including, but not limited to poly-lactic acid
(PLA), poly-L-lactic acid (PLLA), and poly-lactic-co-glycolic acid (PLGA).
III. Methods of Using Nanoparticles and Biodegradable Glass for Soft
Tissue Repair
[0066] In one aspect, the biocompatible, biodegradable composite material
is placed in contact with a body fluid or simulated body fluid. This may be at or
near or in association with a region of interest in body of a mammal such that the
nanoparticles are released into the body fluid(s) at the region of interest as the
glass degrades upon contact with a body fluid(s), such as blood, interstitial
fluid(s), cerebrospinal fluid, or lymph. A region of interest may for example be a
peripheral nerve, or the spine and/or spinal cord. Alternatively, a biocompatible,
biodegradable composite material is placed in contact with a body fluid or
simulated body fluid in vitro.
[0067] For example, chemical dopants such as cerium oxide (CeO2-x)
nanoparticles have been shown to prevent the death of HT22 nerve cells, protect
rat endothelial cells, increase the life span of brain cells, and provide benefits for
the survival of damaged spinal cord cells in rats. Cerium oxide nanoparticles may
also be used to treat, perhaps prevent, Alzheimer's, Parkinson and Huntington's
diseases, and multiple sclerosis. Other elements such as Y, Zn, and Ag may
also be neuroprotective, anti-oxidative, and overall provide improved health of
cells. Therefore, a number of types of chemical dopants may be added to the
glass composition at low weight % .
[0068] As described above and shown for example in FIG. 7,
biocompatible, biodegradable glass composite materials as disclosed herein can
be formed into various shapes and sizes. Different forms may also be usefully
combined with other biocompatible materials to create structures especially
useful for use in soft tissue repair, including any repair of any organ or soft tissue,
for example for wound healing or injured muscle repair. In one aspect, for
example, the composite materials disclosed herein may be used for nerve
regeneration. For example, a common repair mechanism for damaged or
severed nerves involves suturing a nerve guide conduit to opposing ends of a
severed peripheral nerve, to guide growth of the nerve into and through the
conduit for repair. FIG. 14 provides schematic illustrations showing how different
forms of a biodegradable glass composite material as disclosed herein may be
used in such a scheme. Any biodegradable glass composite material as
disclosed herein may be formed for example as a conduit from a rolled polymer
sheet, one or more glass rods, or may be formed as microfibers. FIG. 14
schematically illustrates various structures in the context of the sciatic peripheral
nerve model. As shown at left, a biodegradable glass composite material can be
formed as a cylindrical tube (conduit), for example from a rolled sheet of the
biodegradable glass composite material. Glass rods formed from the
biodegradable glass composite material can be used to build a generally
cylindrical scaffold, either alone or in association with a conduit of the
biodegradable glass composite material, or in association with another matrix or
scaffold material such as a collagen (CN), laminin or other similar gel.
Alternatively, microfibers of the biodegradable glass composite material can be
formed, and these can be embedded in a gel-like scaffold material such as a
collagen gel, fibrin, or collagen+laminin, which may optionally contain or may be
crosslinked to one or more growth factors or therapeutic agents. Such structures
may be usefully implanted at a site of tissue damage to promote repair. For
example, nerves can be easily sutured to a rolled polymer conduit.
[0069] It should be understood that many and various comparable
structural iterations are contemplated by the fact that the biodegradable glass
composite material is amenable to formation into many and various shapes and
sizes for building such structures The resulting structure can be used in the
aforementioned method to support suturing tissue repair, for example, to support
the nerve endings for peripheral repair and/or for embedding the mixed materials
for nerve regrowth. Multiple different biodegradable glass composite materials,
each with a different dopant could be used in combination. The nanoparticle
dopants themselves may be released as the glass reacts with a body fluid or
simulated body fluid, providing a timed release of dopants, growth factors, and/or
therapeutic agents to promote tissue repair. Further, for example, structures
embedded into an injectable matrix such as a collagen gel can be injected at the
site of injury.
[0070] In addition, similar concepts may be utilized for central nervous
tissue repair as in a spinal cord injury (FIG. 15). For instance, a collagen gel may
be formed by containing aligned biodegradable glass rods or microfibers, or both.
For a rod-containing gel, the gel may be formed outside of the site of injury in a
mold that would form a similar shape as the rods cannot be injected; however the
microfibers or frit may be readily suspended and may easily be injected while the
collagen may be a gel. Then, as it forms a gel scaffold structure upon warming to
body temperature, the glass may be embedded and the gel may take the shape
of the injury site. Furthermore, as in the sciatic nerve injury model, the glasses
used may be chemically doped, and either cross-linked to contain releasable
drugs and/or growth factors with time as the glass reacts with the bodily fluids.
Similar concepts may be utilized for any soft tissue injury repair, either injection
at the site or forming a molded gel structure from collagen, fibrin or other types of
gel matrix materials.
[0071] The results described below illustrate the individual aspects for the
feasibility and optimization of this system. Together, they will help to determine
how the biodegradable glass types and various forms could function, and with
particular dopants/factors/drugs to include for the greatest benefit towards
regeneration for the particular tissue. For instance, in the case of tissues that are
highly susceptible to oxidative stress, like nerves, including anti-oxidant dopants
would be beneficial.
[0072] Biodegradable and chemically doped glasses may provide multiple
means to aid and promote neuronal regeneration. Many of these examples of
biodegradable glass may be used in other tissues for tissue regeneration.
EXAMPLES
[0073] The following examples are included to demonstrate the disclosure.
It should be appreciated by those of skill in the art that the techniques disclosed
in the following examples represent techniques discovered by the inventors to
function well in the practice of the disclosure. Those of skill in the art should,
however, in light of the present disclosure, appreciate that many changes could
be made in the disclosure and still obtain a like or similar result without departing
from the spirit and scope of the disclosure, therefore all matter set forth is to be
interpreted as illustrative and not in a limiting sense.
Example 1: Preparation of Parent Glass and Nanoparticles
[0074] A sodium borate glass, with the molar composition of
Na2O.2B2 O 3.xCeO2 (0.001 <x<0.06), was prepared using sodium tetraborate (Alfa
Aesar Ward Hill MA, USA) and cerium oxide (CeO2) (Alfa Aesar Ward Hill, MA,
USA). The powdered raw materials were mixed, the homogeneous mixture was
melted in a platinum crucible at 1000 °C for 1 hour, and stirred several times. The
melt was poured on a cold steel plate and cooled to room temperature, forming a
glass. FIG. 1 shows the XRD pattern of the as-made glass. The absence of
diffraction peaks in the pattern in FIG. 1 indicates the material was no n
crystalline with no identifiable nanoparticles.
[0075] The glass was crushed to particles of less than 150 µιτι in diameter
and 200 mg of the glass particles were reacted in 50 ml of Dl water and
simulated body fluid (SBF) at 37°C for 12 hours. As the glass particles degraded
the solution became cloudy due to formation of ceria nanoparticles. The solution
was centrifuged to separate the nanoparticles from the solution, the residue was
washed with fresh Dl water, sonicated for 5 minutes, and then centrifuged for a
second time. This procedure was repeated several times to insure that any boron
or sodium that had dissolved from the glass was removed.
[0076] Finally, a drop of the solution containing the nanoparticles was
placed on a 400 mesh copper TEM grid coated with a thin-holed carbon, dried at
50°C, and then placed in the TEM. FIG. 2 shows low and high magnification TEM
images of the CeO2-x nanoparticles released from the borate glass as it
degraded in Dl water. The parallel patterns visible in FIG. 2B are lattice fringes
(Planes of atoms in a certain crystal structure) of cerium oxide crystals in a
particular crustal structure. Each nanopartide was identified when the direction of
these patterns changes because each nanoparticle/crystal has parallel planes
(Boundaries of two individual nanoparticles identified by solid lines). The cerium
oxide nanoparticles were crystalline (as indicated by the lattice fringes) and had
an average size of 2-3 nm.
[0077] FIG. 3 shows the nanoparticles formed in Simulated Body Fluid
(SBF) solution. Simulated body fluid is a buffered solution with a pH of 7.4 and
has a composition very close to human blood plasma. The SBF was composed
of the following (in mM): 137.5 NaCI, 3 KCI, 2 MgCI2, 2.6 CaCI2, 4.2 NaHCO 3, 1
K2HPO4, 0.5 Na2SO4, and 50.6 Tris-CI, pH 7.4 at 37°C. Table 1 shows the ion
concentration of SBF and human blood plasma.
Table .
[0078] Nanoparticles formed in SBF were about 50 ± 10 nm in diameter
and had an amorphous (non-crystalline) structure with no lattice fringes/ parallel
lines or patterns. Nanoparticles of yttrium and zirconium oxide may be formed in
Dl water using the same procedure (FIG. 4).
[0079] Table 2 provides examples of parent glass compositions, in mol %
that have been melted.
Table 2 .
Example 2 : Cell growth with nanoparticles
[0080] Embryonic (E1 0-1 1) chick dorsal root ganglia (DRG) were acutely
dissociated and incubated with doped glass in the form of small pieces of glass
(frit). The DRG are comprised of 3 types of cells, neurons and two support cells,
fibroblasts and glia cells. Control cells were grown in the absence of glass. B3
glass refers to the biodegradable borate glass. Additional chemical elements
added to the B3 biodegradable borate glasses are referred to by the chemical
abbreviation. For example, Ce is B3 glass doped with Cerium.
[0081] In the initial experiments, dissociated cells grew as well as, if not
better than control cultures based on qualitative visualization only, for up to 10
days in culture with the following doped glasses: Ce1 , Ce2, Fe, Ga, Zn, and B3.
These glasses were used further for quantification with Live/Dead assay and
counting cells with glass in the form of rods, microfibers and polymer/glass
composite sheets. The doped glass that supported some neuronal or cellular
growth by qualitative visualization includes: Y 1, Y2, Ag, l2, Mn, N2, S, and Sr.
[0082] Quantitative analysis was performed on B3, Ce1 , Ce2, Y 1, and Y2
doped glasses compared to control (without any glass added). The cells were
dissociated, seeded onto wells with the glass added and incubated for 10 days.
Wells were treated with Live/Dead Assay (Molecular Probes) as per the
instructions, and fluorescent images were acquired for each of the wells (4 per
condition) at both 7 and 10 days. Green fluorescence indicates the live cells
(calcein) and red fluorescence indicates the dead cells (ethidium bromide).
Images were acquired individually, merged with Image J, and live and dead cells
were counted. Neurons were distinguished based on their physical aspects of
the cells: larger cells bodies with long and thin processes growing from the cell
body. Fibroblasts are wide and flat, and glia are small round bodies without any
processes. The total number of cells from both live and dead conditions per
merged images was calculated and the fraction of live neurons/total cells for
percent live neurons was determined. The images in FIG. 5 are representative
live images for control cells (without glass added), Ce1 and Y 1 . FIG. 6 is a graph
that depicts the mean +/- standard error of the mean for the 4 different sets of
wells imaged per condition at day 7 and day 10. Statistical analysis was
performed with a two sample t-test with data considered significantly different
than control for the same days in culture (* p<0.05; * * p<0.01 ) . Furthermore, both
Ce and Y incubated for 7 days improved the neuronal survival and growth
compared to either B3 glass without added chemicals (+p<0.01 ) . Preliminary
results show that doped glass with Ce and Y improved the survival over that of
control and B3 only conditions.
Example 3 : Fabrication of biodegradable glass composites
[0083] To fabricate the PCL/biodegradable glass composites, or another
such polymer, as shown in FIG. 7 (polymer sheets), 1.14g of PCL (molecular
weight -70,000) was dissolved in 15 ml of chloroform. The desired amount of
glass particles was then added to the PCL/chloroform solution, stirred for 30 min
and ultrasonicated several times at 1 min intervals. The glass/PCL mixture was
poured onto a polished glass plate and a film of the mixture 8 cm wide and 50 cm
in length was tape-casted using a Dr. Blade set at a thickness of ΘΟΟµιτι . The
composite film was dried at room temperature for 30 min, removed from the
glass plate, and stored in a desiccator. The thickness of the dried films,
measured with a micrometer at several locations, was 60 ± 10 µιτι . The
composition of the 13-93 B3 borate glass (in wt.%) was: 53 B2O3, 20 CaO, 12
K2O, 6 Na2O, 5 MgO, and 4 P2O.
Example 4 : Degradation in Solution
[0084] Noticeable changes in the microstructure and morphology of the
rods and composite polymer sheets occurred after immersion in SBF or cell
culture media. The rods react and degrade with exposure time in the cell culture
media (FIG. 10). When the polymer sheets were exposed to SBF, both sides of
the composite sheet became rougher, and were covered with regions of
submicron crystals of hydroxyapatite (HA, see below). Using scanning electron
microscopy, the fabricated 100% PCL sheet is shown in FIG. 11 compared to
that of 13-93 B3 without any dopants. The micrographs show that the glass
particulates agglomerate during the drying process to form islands, see FIG. 11.
These agglomerates were likely responsible for the rougher surfaces. The
agglomerate islands of the 13-93 B3 composites were nearly covered with
regions composed of hydroxyapatite crystals (inset higher magnification) that
were identified by X-ray diffraction, see FIG. 5 . Cross-section scanning electron
microscopy images show the sub-micron HA microspheres (FIG. 12). Spherical
shapes composed of small HA crystals were also present within the cross section
of the composite film. This image indicates that the PCL-composite sheets were
permeable to the SBF solution since the HA crystals could only have formed if
the 13-93 B3 glass particles had been in contact with the SBF solution.
[0085] Degradation of the 100% PCL and the 13-93 B3 composite in SBF
was determined in two ways: weight loss measurements and analysis of the SBF
solution with inductively coupled plasma (ICP) for elemental analysis of B, Ca,
and P, as a function of time. The weight loss degradation profile for each
composite is shown in FIG. 13A for 14 days of SBF reaction. Weight loss for the
13-93 B3 composite rapidly increased for the first 3 days and reached a
maximum for the duration of the time period compared to the weight loss for the
100% PCL film which was negligible over the 14 day period. Ion release was
measured for the composites for 14 days in SBF. The concentration of B, Ca,
and P released from the 13-93 B3 polymer composite was compared to 100%
PCL (FIG. 13B-D). The average concentration of B released from the 13-93 B3
reached its highest value in 3 days. For Ca release, most of the change occurred
in the first 24 hours, although it was small compared to the nominal 100 ppm Ca
concentration in the starting SBF media. The increase in Ca concentration for the
13-93 B3 composite indicates that this fast reacting glass was releasing Ca,
which temporarily increases the overall super-saturation of the SBF. Eventually,
this leads to the precipitation of the insoluble HA material and accounts for the
slightly lower Ca concentration in the SBF at longer times. The P concentration in
the composites decreased with time. This reduction in P concentration was
consistent to form HA until either the Ca or P was consumed. Similar
experiments can be performed to show the weight loss and ion release effects
with different chemically doped glasses.
Example 5 : Mechanical Property Testing
[0086] Uniaxial tensile testing was performed to assess the mechanical
properties of the composites to confirm that the composites were strong enough
for an initial repair, but degrade within an appropriate time. Unreacted
composites were compared to composites reacted with media for 3 and 6 weeks.
For this experiment, glass composites consisted of 50% 13-93 B3:50% PCL (B3),
50% 45S5 (Bioglass®): 50% PCL (45S5), and 25% 13-93 B3:25% 45S5:50%
PCL (blend) were compared to 100% PCL. Peak stress, strain at break, and
elastic modulus were calculated for all composite samples (FIG. 16). Compared
to unreacted composites, peak stress was only significantly affected after 6
weeks in cell culture media for 100% PCL polymer sheets. PCL alone resulted in
higher peak stresses than any of the biocompatible, biodegradable composite
material sheets at any time point. The blend and 45S5 composites did not show
any significant change in peak stress or strain at break. The elastic moduli also
indicate stiffer properties of PCL and 45S5 sheets compared to the B3 composite
sheets. As expected, the blend of 45S5 and B3 glasses yielded moduli between
the B3 and 45S5 polymer sheets. In addition, PCL and 45S5 polymers trended
toward stiffer moduli with increased time in media, though these results were not
significant. Polymers with B3 did not vary in stiffness with incubation time.
Example 6 : Suture and mechanical strength of conduits
[0087] The biodegradable glass/PCL polymer sheets can be readily rolled
and formed into a conduit. Conduits were formed by rolling the polymer sheet
(single layer ~ 0.06 mm) about 5x, gluing with collagen to form a nerve guidance
conduit that was 15-1 6 mm long, 4.3 mm outer diameter and -0.3 mm inner
thickness (although these dimensions can be easily modified). We sutured
cadaver rat sciatic nerve with 9-0 sutures to one side of each end of the rolled
13-93 B3 conduits (FIG. 17) and performed mechanical strength testing on the
nerves. Each of the strength test resulted in the nerve suture being pulled from
the conduit or the nerve pulling apart from the suture, but not the conduit itself
failing.
Example 7 : Neuronal survival and outgrowth
[0088] To test the effects of the chemically doped glasses on neurons, two
main experiments were conducted to test whether the dopants were a) promoting
or inhibiting survival, and b) promoting or inhibiting neuronal outgrowth as a
model for nerve regeneration. To accomplish this, embryonic (E1 0-1 1) chick
dorsal root ganglia (DRG) were dissociated. The "whole" DRGs are comprised of
3 types of cells: neurons and two support cell types called fibroblasts and glia.
When dissociated, the types of cells can be distinguished from one another
morphologically, neurons have brightly round and clustered cells bodies
interconnected by neurite processes, fibroblasts are flattened broad cells, and
glia are small, polarized cells. In addition, Live cells were stained with Calcein
AM and for Dead cells with eithidium bromide (Live/Dead Assay; Molecular
Probes). Cells were then counted as live neurons, live support cells, or dead
cells. Percentage of live neurons compared to all live cells or total cells were
calculated. FIG. 18 shows a representative image of neurons in culture, stained
for Live/Dead and merged.
[0089] These types of experiments were repeated with biodegradable
borate-based glass without dopants (B3, control) or with chemical dopants. The
cells were dissociated, and cultured for 3 days prior to adding any biodegradable
glasses. For this experiment, all of the cells were exposed to two, 1 cm pieces of
glass that approximated ~ 14 mg/mL of glass reacting in cell culture media. After
3, 7 , or 10 days in culture with the biodegradable glass, cells were counted and
analyzed for survival. Figure 19 shows the average number of neurons alive
(FIG. 19 A) and the average number of support cells alive (FIG. 19 B) for the
doped glass conditions. Each of the dopants is shown labeled below the graph
for three (3) days (medium gray), seven (7) days (dark gray) and ten (10) days
(light gray) of incubation with the glass types. Statistical comparisons are shown
for each of the dopants compared to the control BGG without dopant for the
same day, where the averages that are significantly less than the control are
shown as the pound (#) sign, and the averages significantly greater are shown as
an asterisk (* ) , p<0.05. Figure 20 shows the averaged and normalized percent of
neurons/total live cells (FIG. 20 A) and averaged and normalized support
cells/total live cells (FIG. 20 B) for the dopant glass conditions at 3, 7, and 10
days of exposure. The dead cells were not taken into consideration. Note that the
difference between the two different Ce and Y ( 1 and 2) glasses is that the Ce2
and Y2 are both formulated with a trace amount of iodine, and thus iodine was
tested alone. In addition, the effects of adding 1, 2, 4 and 8 pieces of 1 cm
(7mg/mL) biodegradable glass (FIG. 21) were tested.
[0090] The response of DRG neurons to the biodegradable glass B3/PCL
polymer sheets was determined by measuring the length of neurite outgrowth
from whole DRGs after culture for 3 days on each doped polymer.
Representative images of whole DRGs are shown, and demonstrate that the
neurites survive and extend after culture on the doped polymer composites
compared to the 13-93 B3 (FIG. 22). PCL supports neurite outgrowth very well.
Addition of 13-93 B3 and/or dopant glass particles to PCL show that some of the
dopants improve outgrowth on the composite polymer sheet compared to 13-93
B3 glass without dopant. For example, Zn exhibited increased outgrowth
compared to Ce1 , Ce2, and Y 1 (*p<0.05) and Fe exhibited increased outgrowth
compared to Y 1 (#p<0.05). Overall, the mix of Cu/Zn/Sr/Fe, Fe, and Zn improved
outgrowth over that of 13-93 B3 alone. However, none of the dopants exhibited
any significant decrease compared to the undoped B3 glass. Because the
composite polymer sheets may be used to form a conduit for neurons to grow
within, it was primarily important that none of the dopants would inhibit the
regrowth. When the 13-93 B3 glass was pre-reacted, 13-93 B3 composites
showed a significant increase in neurite outgrowth compared to other undoped
biodegradable glasses of 45S5 and the blend of 45S5/B3/PCL (FIG. 23). These
experiments may be repeated for the pre-reacted doped biodegradable B3
polymer sheets.
[0091] Further data was obtained by measuring the length of the single
longest neurite to grow out from the whole dorsal root ganglia, when measured
from the center of the ganglia after 3 days in culture. The whole ganglia were
placed on top of a poly-L-caprolactone (PCL) polymer sheet of bioactive glass
(50% polymer, 50% doped borate glass). As shown in FIG. 24, compared to
control 13-93B3 polymer glass without dopant, the Fe-, Ga-, and Zn-containing
polymer sheets significantly improve neurite outgrowth. Copper is also tested in
the same way. With iodine, neuronal survival was quite poor over 10 days as
shown in FIGS. 19A and 20A, which indicates that dopant inclusion alone is not
supportive of neuronal growth, but that specific release of particular dopants are
important for neuronal regrowth.
[0092] Interestingly, the chemical dopants that improve the neuronal
survival of single dissociated cells as shown in FIG. 20 are not always the same
dopants that support outgrowth of neurites from a whole ganglion growing on the
surface of the polymer glass composites as shown in FIG. 24. Although it is not
yet known why one dopant supports growth better than the others, ion release
experiments were performed to determine the rate of release of the ions from the
glass fibers used in the experiments for FIGS. 19 and 20, as compared to the
release of ions from the composite PCL polymer sheets on which the whole
dorsal root ganglia are grown, as shown in FIG. 24.
Example 8 : Aligned glass cause aligned growth
[0093] Whole chick dorsal root ganglia (DRG) were seeded onto aligned
13-93 B3 rods "glued" onto thin fibrin or collagen scaffolds to form a "raft" of
biodegradable glass rods. The whole DRG were imaged growing on the aligned
13-93 B3 glass rods as shown in FIG. 25. When the number of neurites were
counted that were growing within each 45 degree angle from 0 to 360 degrees,
and taking the center of the whole DRG as the apex of the angle, the neurites
aligned with the axis of the glass rods as shown in the bar histogram of FIG. 25.
The schematic that shows the angles and neurites were oriented with the aligned
glass fibers. Together, the DRG experiments show that the DRG grow on
biodegradable glass, and when the glass was aligned, neurites extend from the
DRG in an oriented direction.
All patents and publications mentioned in the specification are indicative of
the levels of those skilled in the art to which the present disclosure pertains. All
patents and publications are herein incorporated by reference to the same extent
as if each individual publication was specifically and individually indicated to be
incorporated by reference.
CLAIMS
What is claimed is:
1. A biocompatible, biodegradable composite material for soft tissue repair,
comprising:
a matrix material; and
a parent glass suspended within the matrix material, the parent glass
comprising one or more dopants;
wherein the parent glass releases a plurality of dopant based
nanoparticles when in contact with a body fluid or simulated body fluid.
2 . The biodegradable glass composition of claim 1, wherein the parent glass
comprises sodium tetraborate.
3 . The biodegradable glass composition of claim 1, wherein the dopant is
selected from a metal ion, a transition metal ion, an oxide, a rare earth oxide, a
halide, carbonate, a compound containing a cation, and any combination thereof.
4 . The biocompatible, biodegradable composite material of claim 3, wherein
the dopant is selected from CeO2, Ce2O3 Y2O3, and ZrO2 and mixtures thereof.
5 . The biocompatible, biodegradable composite material of claim 1, wherein
the dopant is selected from cations of Co, Ni, Cu, Ag, Au, Pt, Fe, Ru, Si, V, Cr,
Mn, Fe, Ni, Zn, Sn, Sb, Zn, Ti, Y , Zr, W, La, Ce, Pr, Nd, Sm, Eu, Lu, Yb, Er, Ba,
Ga, I , N, S, Si, and any combination thereof.
6 . The biocompatible, biodegradable composite material of claim 5, wherein
the dopant is selected from the combinations l/Ce, l/Y, l/Ce/P, and Cu/Zn/Sr/Fe.
7 . The biocompatible, biodegradable composite material of claim 1, wherein
the parent glass comprises Na2O.2B 2 O 3.xCeO2 and x ranges from about 0.001 to
about 0.30 moles.
8 . The biocompatible, biodegradable composite material of claim 1, wherein
the material is degradable in vivo.
9 . The biocompatible, biodegradable composite material of claim 1, further
comprising a therapeutic agent.
10 . The biocompatible, biodegradable composite material of claim 1, wherein
matrix material is selected from a polymer, a ceramic, and any combination
thereof.
11. The biocompatible, biodegradable composite material of claim 10, wherein
the matrix material is selected from collagen, laminin, fibrin, PCL, PLA, PLLA,
PEG, PGA, PLGA and any combination thereof.
12 . The biocompatible, biodegradable composite material of claim 1, wherein
the parent glass comprises at least one conformation selected from irregular
particles, microspheres, fibers, rods, ribbons and any combination thereof..
13 . The biocompatible, biodegradable composite material of claim 12, in
which the conformation is combined with a second matrix material.
14. The combination of claim 13, wherein the second matrix material
comprises a scaffold material selected from collagen, laminin, fibrin and any
combination thereof.
15 . The combination of claim 13, wherein the combination has a generally
cylindrical conduit form.
16 . A method of delivering nanoparticles to a region of interest, comprising:
contacting a biocompatible, biodegradable composite material with a body
fluid or simulated body fluid, the biocompatible, biodegradable composite
material comprising:
a matrix material; and
a parent glass suspended within the matrix material, the parent
glass comprising a dopant; and
allowing the parent glass to react or degrade to form and release the
nanoparticles.
17 . The method of claim 16, wherein the glass comprises sodium tetraborate.
18 . The method of claim 16, wherein the dopant is selected from a metal ion,
a transition metal ion, an oxide, a rare earth oxide, a halide, carbonate, a
compound containing a cation, and any combination thereof.
19 . The method of claim 18, wherein the dopant is selected from CeO2, Y2O3,
20. The method of claim 16, wherein the dopant is selected from Co, Ni, Cu,
Ag, Au, Pt, Fe, Ru, Si, V, Cr, Mn, Fe, Ni, Zn, Sn, Sb, Zn, Ti, Y, Zr, W , La, Ce, Pr,
Nd, Sm, Eu, Lu, Yb, Er, Ba, Ga, I , N, S, Si, and any combination thereof.
2 1 . The method of claim 20, wherein the dopant is selected from the
combinations l/Ce, l/Y, l/Ce/P, and Cu/Zn/Sr/Fe.
22. The method of claim 16, wherein the parent glass comprises
Na2O.2B2O3.xCeO2 and x ranges from about 0.001 to about 0.30 moles.
23. The method of claim 16, wherein the biocompatible, biodegradable
composite material further comprises a therapeutic agent.
24. The method of claim 16, wherein the matrix material is selected from a
polymer, ceramic, and any combination thereof.
25. The method of claim 24, wherein the matrix material is a polymer selected
from collagen, laminin, fibrin, PCL, PLA, PLLA, PEG, PGA, PLGA, and any
combination thereof.
26. The method of claim 16, wherein the parent glass comprises at least one
conformation selected from irregular particles, microspheres, fibers, rods,
ribbons, and any combination thereof.
27. The method of claim 16, in which the conformation is combined with a
second matrix material.
28. The method of claim 27, wherein the second matrix material comprises a
scaffold material selected from collagen, laminin, fibrin and any combination
thereof.
29. The method of claim 27, wherein the combination has a generally
cylindrical conduit form.
30. The method of claim 16, wherein the body fluid is associated with a region
of interest.
3 1 . The method of claim 30, wherein the region of interest is selected from a
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